Search

Author/Creator Dow, Edward

1. A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. (3rd May 2017)

Authors:
Laubach, Jacob P.; Moslehi, Javid J.; Francis, Sanjeev A.; San Miguel, Jesús F.; Sonneveld, Pieter; Orlowski, Robert Z.; Moreau, Philippe; Rosiñol, Laura; Faber, Edward A.; Voorhees, Peter; Mateos, Maria‐Victoria; Marquez, Loreta; Feng, Huaibao; Desai, Avinash; van de Velde, Helgi; Elliott, Jenni...
Journal:
British journal of haematology
Issue:
Volume 178:Number 4(2017)
Page Start:
547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ACT-13 DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (3rd December 2022)

Authors:
Yoshiki, Arakawa; Reardon, David; Narita, Yoshitaka; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard
Journal:
Neuro-oncology advances
Issue:
Volume 4(2022)Supplement 3
Page Start:
iii8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. (15th December 2015)

Authors:
Ali, Siraj M.; Pal, Sumanta K.; Wang, Kai; Palma, Norma A.; Sanford, Eric; Bailey, Mark; He, Jie; Elvin, Julia A.; Chmielecki, Juliann; Squillace, Rachel; Dow, Edward; Morosini, Deborah; Buell, Jamie; Yelensky, Roman; Lipson, Doron; Frampton, Garrett M.; Howley, Peter; Ross, Jeffrey S.; Stephens,...
Journal:
Oncologist
Issue:
Volume 21:Number 1(2016)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib‐melphalan‐prednisone in the phase III VISTA study. Issue 4 (27th February 2015)

Authors:
Mateos, María Victoria; Richardson, Paul G.; Dimopoulos, Meletios A.; Palumbo, Antonio; Anderson, Kenneth C.; Shi, Hongliang; Elliott, Jennifer; Dow, Edward; van de Velde, Helgi; Niculescu, Liviu; San Miguel, Jesús F.
Journal:
American journal of hematology
Issue:
Volume 90:Issue 4(2015:Apr.)
Page Start:
314
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. RTID-03. DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (14th November 2022)

Authors:
Reardon, David A; Narita, Yoshitaka; Arakawa, Yoshiki; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗